PengYun Li - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

PengYun Li

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

Journal of Medicinal Chemistry|April 7, 2026

Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer ImmunotherapyYalei Wang, Zhenze Qi, Shiyang Sun, et al.

Journal of Medicinal Chemistry|March 20, 2026

Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid TumorsTingting Yang, Ting Wei, Shiyang Sun, et al.

Cell Metabolism|September 26, 2017

Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and ObesityCarmelo Quarta, Christoffer Clemmensen, Zhimeng Zhu, et al.

Pageof 12

Search research articles

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

Journal of Medicinal Chemistry|April 7, 2026

Discovery of Highly Potent and Selective IKZF2 Degraders for Cancer ImmunotherapyYalei Wang, Zhenze Qi, Shiyang Sun, et al.

Journal of Medicinal Chemistry|March 20, 2026

Structure-Based Discovery of Novel, Highly Potent VEGFR2 Inhibitors with a Naphthalene Scaffold against a Broad Range of Solid TumorsTingting Yang, Ting Wei, Shiyang Sun, et al.

Cell Metabolism|September 26, 2017

Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and ObesityCarmelo Quarta, Christoffer Clemmensen, Zhimeng Zhu, et al.

Pageof 12